Literature DB >> 8161961

An ambulatory bile reflux monitoring system: an in vitro appraisal.

M T Caldwell1, P J Byrne, N Brazil, V Crowley, S E Attwood, T N Walsh, T P Hennessy.   

Abstract

Assessment of duodenogastric bile reflux has hitherto been unsatisfactory. An ambulatory system which utilizes the optical properties of bilirubin is examined. Test readings are correlated with the laboratory values for bilirubin in each of a number of physiological solutions. For dilutions of pure bile there was a linear correlation between absorbance and bilirubin concentration (r = 0.93, p < 0.001). In the more acidic environment of gastric juice there was also a linear correlation between absorbance and bilirubin concentration (r = 0.65, p < 0.001), but absorbance values were significantly higher than those of pure bile solutions (F ratio = 130, p < 0.0001). Normal gastric secretions and saliva give low absorbance values (0.02-0.04). Common foodstuffs such as soups, tea and coffee give higher readings and may interfere with bile reflux assessment in a clinical setting. Bilitec 2000 has potential for use as an ambulatory bile reflux monitoring system but consideration should be given to a standard diet or attention must focus on the fasting period.

Entities:  

Mesh:

Year:  1994        PMID: 8161961     DOI: 10.1088/0967-3334/15/1/005

Source DB:  PubMed          Journal:  Physiol Meas        ISSN: 0967-3334            Impact factor:   2.833


  13 in total

1.  Reconstructive procedure after distal gastrectomy for gastric cancer that best prevents duodenogastroesophageal reflux.

Authors:  Kenichiro Fukuhara; Harushi Osugi; Nobuyasu Takada; Masashi Takemura; Masayuki Higashino; Hiroaki Kinoshita
Journal:  World J Surg       Date:  2002-10-10       Impact factor: 3.352

2.  Early and late results of the acid suppression and duodenal diversion operation in patients with barrett's esophagus: analysis of 210 cases.

Authors:  Attila Csendes; Patricio Burdiles; Italo Braghetto; Owen Korn; Juan Carlos Díaz; Jorge Rojas
Journal:  World J Surg       Date:  2002-03-01       Impact factor: 3.352

3.  Dietary restrictions during ambulatory monitoring of duodenogastroesophageal reflux.

Authors:  Jan Tack; Raf Bisschops; Gerardus Koek; Daniel Sifrim; Tony Lerut; Jozef Janssens
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

4.  Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's oesophagus.

Authors:  R E Marshall; A Anggiansah; D K Manifold; W A Owen; W J Owen
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

5.  A new physiologic approach for the surgical treatment of patients with Barrett's esophagus: technical considerations and results in 65 patients.

Authors:  A Csendes; I Braghetto; P Burdiles; J C Díaz; F Maluenda; O Korn
Journal:  Ann Surg       Date:  1997-08       Impact factor: 12.969

6.  Bio-sensor system discriminating between the biliary and pancreatic ductal systems.

Authors:  O J Pallotta; G T P Saccone; R E Woolford
Journal:  Med Biol Eng Comput       Date:  2006-03-15       Impact factor: 2.602

7.  Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity.

Authors:  D Nehra; P Howell; C P Williams; J K Pye; J Beynon
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

8.  Anatomic dilatation of the cardia and competence of the lower esophageal sphincter: a clinical and experimental study.

Authors:  O Korn; A Csendes; P Burdiles; I Braghetto; H J Stein
Journal:  J Gastrointest Surg       Date:  2000 Jul-Aug       Impact factor: 3.452

9.  Analysis of ambulatory duodenogastroesophageal reflux monitoring.

Authors:  R Cuomo; G Koek; D Sifrim; J Janssens; J Tack
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

10.  Bile acids and total bilirubin detection in saliva of patients submitted to gastric surgery and in particular to subtotal Billroth II resection.

Authors:  Eugenio De Corso; Silvia Baroni; Stefania Agostino; Giovanni Cammarota; Giovanni Mascagna; Alice Mannocci; Mario Rigante; Jacopo Galli
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.